Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC10H16N2O2S4 |
InChIKeyKKVYOWPPMNSLCP-UHFFFAOYSA-N |
CAS Registry729-46-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 15 Nov 2015 |